Histomorphological study of mucormycosis in COVID-19 patients
Keywords:
COVID-19, mucormycosis, histopathologyAbstract
Background: Mucormycosis is a rapidly progressive angioinvasive fungal infection which has a high rate of mortality and morbidity. Mucormycosis most commonly invades the nose and paranasal sinuses presenting as rhinosinusitis. We noted an upsurge in the number of patients affected with Mucormycosis during Covid-19 infection era. Aim: Our study aims to illustrate the histopathology of Mucormycosis in post-Covid-19 patients and also to study the fungal morphology by utilizing special stains. Materials and Methods: We prospectively analysed the histopathological findings of fungal elements in 260 different histopathological samples of mucormycosis in post-covid-19 patients. The clinical and histopathological findings were noted and tabulated. Statistical Analysis Used: The data collected was tabulated and coded in Microsoft excel. All the data of demographic and clinical characteristics were analysed by descriptive statistics and percentage. Tables and graphs were added wherever applicable. Results: Out of 260 cases analysed, most of the patients presented with periorbital swelling followed by headache and nasal block. Histopathologically, most of the cases showed chronic inflammatory reaction with wide areas of necrosis and granuloma formation. The fungal elements have been appreciated and sensitivity of different stains to appreciate the fungal structures have been compared.
Downloads
References
World Health Organization. WHO virtual press conference on COVID-19. March 11, 2020.
Bedford J, Enria D, Giesecke J et al. COVID-19: Towards controlling of a pandemic. Lancet. 2020; 395: 1015-1018.
Zhu N et al. Early transmission Dynamics in Wuhan, China of Novel Corona virus infected pneumonia.N Engl J Med 2020; 382:1199-1207.
GeSong .GuanzhaoLiang .Weida Liu. Fungal Co-infections Associated with Global COVID-19 Pandemic: A Clinical and Diagnostic Perspective from China.2020. Mycopathologia https://doi.org/10.1007/s11046-020-00462-9.
Sahil Mehta &AbhaPandey.Rhino-orbital Mucormycosis associated with Covid 19.Cereus .2020;12(9)
Petrikkos G, Skiada A, Lortholary O et al. Epidemiology and clinical manifestations of mucormycosis. Clin Infect Dis. 2012; 54: S23–S34.
Farmakiotis D, Kontoyiannis DP. Mucormycosis. Infect Dis Clinf North Am. 2016; 30: 143–163.
Spellberg B, Edwards J, Ibrahim A. Novel perspectives on mucormycosis: pathophysiology, presentation and management. ClinMicrobiol Rev. 2005; 18: 556–569.
Frater JL, Hall GS, Procop GW. Histologic features of zygomycosis: emphasis on perineural invasion and fungal morphology. Arch Pathol Lab Med. 2001; 125: 375–378.
Werthman-Ehrenreich A (2020) Mucormycosis with orbital compartment syndrome in a patient with COVID-19. Am J Emerg Med S0735–6757(20):30826–30833.
Guarner J, Brandt ME. Histopathologic Diagnosis of Fungal Infections in the 21st Century. ClinMicrobiol Rev. 2011;24(2):247– 80. doi:10.1128/cmr.00053-10.
Kim JH, Jeong YH, Park HJ, Kim DS, Kim SJ, Lee SW, et al. Investigation of spudcan–soil interaction in a sloped seabed using centrifuge model tests. EurRadiol. 2018;8(2):788–95.
Singh AK, Singh R, Joshi SR, et al. Mucormycosis in COVID-19: a systematic review of cases reported worldwide and in India. Diabetes Metab Syndr 2021; 15(4): 102146.
Prakash H and Chakrabarti A. Epidemiology of mucormycosis in India. Microorganisms 2021; 9(3): 523.
Jain K, Surana A, Choudhary TS, Vaidya S, Nandedkar S, Purohit M. Clinical and histology features as predictor of severity of mucormycosis in post-COVID-19 patients: An experience from a rural tertiary setting in Central India. SAGE open medicine. 2022 Feb; 10:20503121221074785.
Afroze SN, Korlepara R, Rao GV, Madala J. Mucormycosis in a diabetic patient: A case report with an insight into its pathophysiology. Contemp Clin Dent 2017;8:662-6.
Kajs Wyllie M. Hyperbaric oxygen therapy for rhinocerebral fungal infection. J Neurosci Nurs 1995;27:174 81.
Jeong W, Keighley C, Wolfe R, et al. The epidemiology and clinical manifestations of mucormycosis: a systematic review and meta-analysis of case reports. Clin Microbiol Infect 2019;25: 26–34.
Müller JA, Groß R, Conzelmann C, et al. SARS-CoV-2 infects and replicates in cells of the human endocrine and exocrine pancreas. Nat Metab 2021; 3: 149–165.
Published
How to Cite
Issue
Section
Copyright (c) 2023 International journal of health sciences
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Articles published in the International Journal of Health Sciences (IJHS) are available under Creative Commons Attribution Non-Commercial No Derivatives Licence (CC BY-NC-ND 4.0). Authors retain copyright in their work and grant IJHS right of first publication under CC BY-NC-ND 4.0. Users have the right to read, download, copy, distribute, print, search, or link to the full texts of articles in this journal, and to use them for any other lawful purpose.
Articles published in IJHS can be copied, communicated and shared in their published form for non-commercial purposes provided full attribution is given to the author and the journal. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
This copyright notice applies to articles published in IJHS volumes 4 onwards. Please read about the copyright notices for previous volumes under Journal History.
